Coulbourn Instruments Release: Novel FreezeFrame Application With Optogenetics

Published: Oct 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ocotober 11, 2013 -- FreezeFrame software for Fear Conditioning, Tail Suspension and Porsolt Swim Testing from Coulbourn Instruments was highlighted recently in the New York Times and the prestigious British publication, The Guardian. A study by the Tonegawa lab at the RIKEN-MIT Center for Neural Circuit Genetics details how false memories were created by optogenetic manipulation in the hippocampus of mice and tested under different contexts with FreezeFrame.

FreezeFrame offers these unique features:

- First video–based system for fear conditioning, known for being the standard within the field

- Ability to detect minute movements of grooming, sniffing, turning and rearing

- Superior for low light performance

- Utilizes a proprietary motion detection algorithm to filter out shadows, light flicker and camera noise while detecting movement as fine as 1 mm

- Multiple stimulus protocol capabilities

- Stored video images are exported as QuickTime and AVI movies

FreezeFrame software works in conjunction with a USB interface and Coulbourn modular operant boxes to provide the complete stimulus control required for fear conditioning applications. This software can also be used to detect bouts of freezing in other applications such as forced swim and tail suspension tests.

For additional information, contact Coulbourn’s experts in behavioral research applications to assist in selecting the best system configuration for your needs.

Coulbourn Instruments is a global developer, manufacturer, and distributor of innovative and specialized products to enhance bioresearch.

For more information, contact:

Coulbourn Instruments

5583 Roosevelt Street

Whitehall, PA 18052

Phone: 610-395-3771

Toll Free: 800-424-3771

Fax: 610-391-1333



Help employers find you! Check out all the jobs and post your resume.

Back to news